Electrophysiology and heart failure: ViewpointProphylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: A pooled analysis of 10 primary prevention trials
Under an Elsevier user license
open archive
Abbreviations and acronyms
ACE
angiotensin-converting enzyme
AMIOVIRT
Amiodarone Versus Implantable Cardioverter-Defibrillator Randomized Trial
CABG-Patch
Coronary Artery Bypass Graft Patch trial
CAT
Cardiomyopathy Trial
CI
confidence interval
COMPANION
Comparison of Medical Therapy, Pacing, and Defibrillation in Patients With Left Ventricular Systolic Dysfunction trial
CRT
cardiac resynchronization therapy
DEFINITE
Defibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation trial
DINAMIT
Defibrillator In Acute Myocardial Infarction Trial
EP
electrophysiology
ICD
implantable cardioverter-defibrillator
LV
left ventricular
MADIT
Multicenter Automatic Defibrillator Implantation Trial
MUSTT
Multicenter Unsustained Tachycardia Trial
RR
relative risk
SCD-HeFT
Sudden Cardiac Death in Heart Failure Trial
Cited by (0)
Dr. Nanthakumar is supported by the clinician scientist program of the Canadian Institute of Health Research. We would like to disclose that there is potential conflict of interest in that all authors of this manuscript except Dr. Lee’s care for patients with these devices. Dr. Epstein chairs events committees for St. Jude Medical and Guidant Corp., and has been a speaker for Biotronik, Guidant Corp., Medtronic Inc., and St Jude Medical. Drs. Kay, Epstein, and Plumb are investigators for Guidant Corp., St. Jude Medical, Medtronic Inc., and Biotronik. Dr. Nanthakumar is an investigator for Medtronic Inc. In addition, Dr. Kay is a consultant for Guidant Corp.
Copyright © 2004 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.